Vimarsana
Biggest News Aggregation in the World

Mortimerb Davis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mortimerb Davis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mortimerb Davis Today - Breaking & Trending Today

Quarterly, Semiannual Zilebesiran Injection Improves Blood Pressure Control - Vimarsana News

Quarterly, Semiannual Zilebesiran Injection Improves Blood Pressure Control

Zilebesiran targets hepatic angiotensinogen production. Investigators evaluated the blood pressure-lowering ability and safety of various zilebesiran dosing regimens.

5 Best Covid Treatment Stocks to Buy Today - Vimarsana News

5 Best Covid Treatment Stocks to Buy Today

39 of the 943 hedge funds part of Insider Monkey's database had held a stake in the company during last year's fourth quarter.

World first: Researchers identify specific re - Vimarsana News

World first: Researchers identify specific re

For the first time, researchers have identified specific regions of the brain that are damaged by high blood pressure and may contribute to a decline in mental processes and the development of dementia. High blood pressure is known to be involved in causing dementia and damage to brain function. The study, which is published in the European Heart Journal, shows how this happens.

Study Links High Blood Pressure with Damage to Brain Regions and Cognitive Decline - Vimarsana News

Study Links High Blood Pressure with Damage to Brain Regions and Cognitive Decline

Researchers hope that findings could help point to new approaches to treating cognitive impairment in people with high blood pressure.

SUNSHINE BIOPHARMA, INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Vimarsana News

SUNSHINE BIOPHARMA, INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 1.01. Entry into a Material Definitive Agreement. On February 7, 2023, Sunshine Biopharma, Inc. received a duly executed research agreement with Sir Mortimer B. Davis Jewish General Hospital,... | February 10, 2023